Who is sponsoring NCT06145672?

NCT06145672 is sponsored by Assiut University.

What drugs are being tested in NCT06145672?

Interventions in NCT06145672: follicular unit extraction and implantaion.

What condition does NCT06145672 study?

NCT06145672 studies Alopecia Scar.

Is NCT06145672 still recruiting?

NCT06145672 is currently status unknown. Last updated 24 November 2023.

Last reviewed 2023-11-24 · How we verify

NCT06145672

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Treatment of Alopecic Scars by Follicular Unit Extraction Hair Transplantation

Status unknown NA Last updated 24 November 2023

What this trial tests

NA trial testing follicular unit extraction and implantaion in Alopecia Scar in 40 participants. Status unknown.

Timeline

1 December 2023

Primary endpoint
1 December 2024

1 December 2024

Quick facts

Lead sponsor	Assiut University
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	40
Start date	1 December 2023
Primary completion	1 December 2024
Estimated completion	1 December 2024

Drugs / interventions tested

follicular unit extraction and implantaion

Conditions studied

Alopecia Scar — all drugs for Alopecia Scar →

Sponsor

Assiut University

Who can join

Adults 15 to 60, any sex, with Alopecia Scar. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aim: is to completely hide the alopecic scars in a way that it will not be visible.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Assiut University trials

Trials by the same sponsor.

NCT07423312 — Lead Exposure and Multiple Sclerosis · not yet recruiting
NCT07234526 — Usage of Glucose Fluctuations as a Prognostic Marker in Septic Shock Patients · not yet recruiting
NCT07273214 — Knowledge, Attitude and Practice of Third Trimester Pregnant Mothers Towards Self-Medication in Assiut, Egypt · not yet recruiting
NCT07194863 — Efficacy of Essential Phospholipid Versus Betaine HCL/L-Glutamic Acid in MAFLD · not yet recruiting
NCT07053709 — Screening for Hyperuricemia in Patients With Metabolic Associated Fatty Liver Disease (MAFLD) · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06145672 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Assiut University
Last refreshed: 24 November 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06145672.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing